Stay updated on Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Sign up to get notified when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The website has removed the detailed options for downloading data in various formats, including CSV, JSON, and RIS, along with the associated data fields and selection options.
    Difference
    14%
    Check dated 2024-11-23T04:57:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Several key government health and information websites have been removed from the monitored list.
    Difference
    0.7%
    Check dated 2024-11-16T00:23:31.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new links to health-related resources and providing enhanced options for downloading study data in various formats.
    Difference
    17%
    Check dated 2024-11-08T18:39:53.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.3%
    Check dated 2024-11-01T11:08:24.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.
    Difference
    0.7%
    Check dated 2024-10-25T00:56:20.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-10-03T05:02:29.000Z thumbnail image

Stay in the know with updates to Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.